Hepatic Encephalopathy
description
Transcript of Hepatic Encephalopathy
![Page 1: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/1.jpg)
Hepatic Encephalopathy
Presented by:Mohannad A. Almikhlafi
Ahmed M. Aljabri
Supervised by:Prof. Dr.Mahmood Abdulmenem
![Page 2: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/2.jpg)
Key Points• Epidemiology & definition• Etiology• Pathogenesis• Stages of H.E.• Sign and Symptoms• Diagnosis• Ascites• Case presentation
![Page 3: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/3.jpg)
EpidemiologyCirrhosis affects 3.6 per 1000
adults in the United States and is responsible for 26,000 deaths per year.
Chronic liver disease represents the fourth leading cause of deaths among all races and sexes in the 45- to 54-year-old age group, exceeded only by malignancy, heart disease, and accidents.
![Page 4: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/4.jpg)
DefinitionIt is a neuropsychiatric disturbances caused by liver disease.
![Page 5: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/5.jpg)
• HE is due to cerebral intoxication by nitrogenous compounds produced by bacteria in GIT .
• Several nitrogenous compounds have been implicated as causes of HE : they include ammonia , false transmitters & fatty acids.
Pathogenesis
![Page 6: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/6.jpg)
Pathogenesis
• In the presence of poor hepatocellular function ,nitrogenous compound in the portal venous blood pass in to the systemic circulation with out being metabolized by the liver, & cross BBB.
![Page 7: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/7.jpg)
Pathogenesis
![Page 8: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/8.jpg)
Infections Constipation GIT bleeding Excess protein intake Hypokalemia, Metabolic-alkalosis
(vomiting, diarrhea , dehydration) Azotemia Drugs ( Diuretic, sedative ,hypnotic) Renal failure.
Precipitaiting factors
![Page 9: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/9.jpg)
Stage 1- Mild confusion, decreased attention, irritability, reversed sleep pattern.Stage 2- Drowsiness, personality changes, intermittent disorientationStage 3- Somnolence , disorientation, marked confusion, slurred speech Stage 4- Frank coma
Stages of HE:
![Page 10: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/10.jpg)
Sign and Symptom Some of the following signs and
symptoms may occur in the presence of cirrhosis or as a result of the complications of cirrhosis:
• Abdominal swelling.• Nausea ,vomiting.• Dark urine.• Sleep disturbances.
![Page 11: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/11.jpg)
Cont.• Caput Medusa.• Fetor hepaticus .• Jaundice , itching.• Hepatomegaly , splenomegaly.• Flapping tremors.• Gynecomastia.• Melena , fatigue.
![Page 12: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/12.jpg)
Diagnosis
• Laboratory: CBC, LFT, Kidney function, serum
electrolyte.
• Radiology.
• Liver biopsy.
![Page 13: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/13.jpg)
Laboratory tests
1- Hypoalbuminemia2- Elevated prothrombin time3- Thrombocytopenia4- Elevated alkaline phosphates5- Elevated aspartate transaminase (AST)
alanine transaminase (ALT)6- Elevated glutamyl transpeptidase
(GGT)
![Page 14: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/14.jpg)
• Radiology• X-ray , CT, US & radioisotope scan.
• biopsy• Definitive diagnosis depend on biopsy
& microscopic interpretation.
![Page 15: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/15.jpg)
Ascites• Is the pathologic accumulation of
lymph fluid within the peritoneal cavity.
• It is one of the earliest and most common presentations of cirrhosis.
• Spontaneous bacterial peritonitis (SBP) may occur & have a high mortality rate.
![Page 16: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/16.jpg)
Cont.It is due to :
• Portal hypertension.
• Hypoalbuminemia (due to failure of liver to form plasma protein).
• Hyperaldosteronism (due to failure of liver to inactivation of aldosterone).
![Page 17: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/17.jpg)
Precipitating factors:
• ↑Protein load in the intestine(↑protein intake, Constipation & GIT bleeding)
• Electrolyte disturbance(hypokalemia-metabolic alkalosis)
• Dehydration
• CNS depressant drugs(hypnotics , opioids &sedatives)
![Page 18: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/18.jpg)
Management
Of HE
![Page 19: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/19.jpg)
Goal of therapy
To reduce nitrogen load in the GIT
To correct any metabolic or electrolyte disturbance that may arise.
![Page 20: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/20.jpg)
1.Lactulose: o Inhibit intestinal bacteria
o absorption of nitrogenous waste product
o Laxative effect to remove nitrogenous wastes.
Dose: 20-60 ml 3 times/day, Titrated to
achieve 2-4 soft stools / day without diarrhea.
![Page 21: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/21.jpg)
o Maximum laxative effect appear at 2-4 days Enema should be used during the initial 2 days
SE: Flatulence , Diarrhea ,
dehydration, Gaseous distention.
![Page 22: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/22.jpg)
2.Antibiotics:
• Neomycin – 1g/6hrs– SE: ototoxicity and nephrotoxicity
• Metronidazole– 400 mg /6hrs– SE: Headache, ataxia, pancreatitis .
![Page 23: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/23.jpg)
Contraindicated Drugs
• Execs diuretic
• Sedative & hypnotic drugs
• Drug have toxic effect on the liver
![Page 24: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/24.jpg)
Parameters used to monitor Therapeutic
effect:1-Biochemical parameters:Serum ammoniaSerum electrolyte levelsBUN
2-Clinical parameters:Improvement of symptoms &
physical signs of HE
![Page 25: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/25.jpg)
Management
Of Ascites
![Page 26: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/26.jpg)
Goal of therapy:1- Removal of ascitic fluid.2- Prevention of complication esp. SBP.3- Correction of any serum biochemical
abnormality.
![Page 27: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/27.jpg)
Lines of TherapyA- Rest with restriction of sodium (only 2g/d) - Serum biochemical analysis determine if
fluid restriction is needed. - Restriction of water should be done if
hyponatremia is present .
![Page 28: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/28.jpg)
B- Diuretics: Diuresis should be gradual because
hypokalemia or intravascular volume depletion caused by aggressive therapy compromised renal function, and hepatic encephalopathy.
![Page 29: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/29.jpg)
Patients have increased serum aldosterone due to:
-Increased production due to decreased intravascular volume and decreased renal perfusion Activation of RAAS.
-Decreased excretion due to hepatic impairment decreased metabolism.
![Page 30: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/30.jpg)
1- Spironolactone: Block aldosterone redeptors.Indication: Diuretic of choice in treatment of ascites
and edema due to liver cirrhosis.Dose:100-400mg once daily. Dose Adjusted after 2 days at least
because maximum effect is after 2-4 days.
![Page 31: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/31.jpg)
Adjusted according to: -Clinical parameters effective dose
decreases weight by 0.5kg/d (if ascites) and 1kg/d (if ascites and lower limb edema).
-Biochemical parameters hyperkalemia, hyponatremia, urea and creatinine to avoid renal impairment
![Page 32: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/32.jpg)
Precautions:• Hyperkalemia continuous serum
potassium monitoring.
• Urea and creatinine should be measured because spironolactone is contraindicated in renal failure.
![Page 33: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/33.jpg)
2- Furosemide:• If spironolactone was inadequate or no
response or appearance of side effects, furosemide (20-40mg/d) is added.
• We start with both in initial doses and increase dose by same rate.
![Page 34: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/34.jpg)
C- Antibiotics:• Third generation cephalosporin
e.g.cefotaxime 1g/12hr IV for 1 week.• Quinolones e.g. oral Ofloxacin or
norfloxacin 400mg BID for 1 week.
![Page 35: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/35.jpg)
D- Paracentesis: • Which is removal of ascitis fluid (4- 6L)
from the abdominal cavity with a needle or catheter.
• Indicated in tense ascites.
• Fluid is rich in albumin for every 1 L removed give 6-8g albumin.
![Page 36: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/36.jpg)
E- TIPS (transjugular intrahepatic portosystemic shunt)
• Indicated If paracentesis is not effective
• Nonsurgical technique to place one or more stents between the hepatic vein and the portal vein.
![Page 37: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/37.jpg)
Case presentation
![Page 38: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/38.jpg)
I.A. is a 62 years old Egyptian male admitted to ED of KAUH on 13 May, 2009.
Confusion since today morning, disorientation, lethargy, abdominal pain, constipation.
![Page 39: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/39.jpg)
• Past medical history:
DM ( on OHG agent), CLD(LC, Hematemesis), HCV, HBV, Portal hypertension, post spleenoctomy, esophagitis.
• Family history: No family history of similar condition.
![Page 40: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/40.jpg)
• Home medications:o Glimepiride 3 mg PO OD o Metformin 500 mg PO BID Furosemide 40 mg PO OD Lactulose 30 mL PO TID ( D/C 4 days before admission)
• Diagnosis: Hepatic encephalopathy
![Page 41: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/41.jpg)
Vital signs:RR: 22 BP: 135/78 Pulse: 75 bpm Temp: 36.22º C
Lab:Na: 144 mmol/L K: 4.1 mmol/L Bilirubin: 7 umlo/L Cr: 100 umol/LGlucose: 12.1 mmol/L CK: 2468 IU/LAlbumin: 22 g/L ALT: 69 U/LAST: 110 U/L GGT: 92 U/L Troponin-I 1.6 ug/l
13/5
![Page 42: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/42.jpg)
Examination:o General condition: Disorientation &
Confusiono Skin: No jaundice, no skin rasho CVS: S1 + S2 + 0o CNS: Normal reflexes, flapping tremorso Chest: Bilateral basal crepitationo Abdomen: Distended, soft, lax,
hepatomegally, mild ascitits
![Page 43: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/43.jpg)
PLAN
Lab: CBC, LFT, PT, APTT, U&E, PCR HBV DNA & HCV RNA.
Medications:Furosemide 40 IV BIDLactulose 30 mL PO TIDLactulose enema 300 mL PR ODCeftriaxone 2gm IV OD Insulin sliding scale S.C Q 6hrOrnithine (hepamerz®)1 Sachet
![Page 44: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/44.jpg)
• Currently ptn is conscious, oriented, free of pain, no abdominal pain, no tenderness, no melena, mild ascites.
• Normal vital signs
Propranolol 10 mg PO BIDAlbumin 100 mL IV OD for 2 daysOmeprazol 40 mg PO OD
14/5
![Page 45: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/45.jpg)
Patient is stable, conscious, oriented.
Plan:D/C Ceftriaxone, ISSAdjustment for Lactulose frequency TID QID & for Furosemide route of administration IV PO
16/5
Glimepiride 3 mg PO OD Metformin 500 mg PO BID
Discharge tomorrow
![Page 46: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/46.jpg)
• Patient was discharged.
• Discharge medications:o Omeprazole 20 mg PO ODo Propranolol 20 mg BIDo Lactulose 30 mL PO QIDo Glimepiride 3 mg PO ODo Metformin 500 mg PO BID
17/5
![Page 47: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/47.jpg)
Assessmento Furosemide is not prefer because of:
Potent & rapid acting (ptn had mild ascites) hypovolemia aggravate HE
SE: hypokalemia (metabolic alkalosis)
• Spironolactone is the drug of choice for ascites (mild diuresis, antagonize
aldosterone) starting with 100 mg OD titrated to 300 mg/day if no response.
![Page 48: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/48.jpg)
• Norfloxacin is the prophylactic drug of choice for SBP.
• Lactulose effect will start after 2-3 days, so, giving lactulose enema is a good decision.
![Page 49: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/49.jpg)
• Therapeutic dose of Lactulose is the dose that produce 4 soft stool without diarrhea.
• The right Propranolol dose is the dose that decrease pulse baseline by 25% (but not ˂ 60 bpm).
![Page 50: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/50.jpg)
• Diuretics and beta-blockers may increase the risk of hyperglycemia so, carful monitoring for blood sugar level.
• Beta-blockers may mask symptoms of hypoglycemia such as tremors and tachycardia, other symptoms:
headache, dizziness, drowsiness, nausea, hunger, and sweating may be unaffected.
![Page 51: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/51.jpg)
• Laxatives can cause significant losses of fluid and electrolytes, including Na, K, Mg and zinc, that may be additive to those of diuretics, so carful monitoring for these parameters & any signs of fluid & electrolyte depletion.
• Most complaints about lactulose are nausea (due to sweet taste of the drug),
diarrhea, flatulence.
![Page 52: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/52.jpg)
THANKS
![Page 53: Hepatic Encephalopathy](https://reader034.fdocuments.in/reader034/viewer/2022050821/568164f3550346895dd75c54/html5/thumbnails/53.jpg)
Reference• http://www.nlm.nih.gov/medlineplus/en
cy/article/000302.htm
• http://emedicine.medscape.com/article/186101-overview
• http://www.gastroresource.com/gitextbook/en/chapter14/14-13.htm
• http://www.umm.edu/ency/article/000302.htm